More recently, it has been shown that PD-1 expression was significantly higher on CD4+ T cells and T-cell immunoglobulin and mucin containing protein 3 (TIM-3) expression was significantly higher on CD8+ T cells in blood of melanoma patients that respond to anti-PD-1 therapy compared to non-responders [89]. Here, CD4 is linked to melanoma.